Thursday, April 10, 2008

Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2008

SOUTH JORDAN, Utah, April 10 /PRNewswire-FirstCall/ -- Merit Medical
Systems, Inc. (Nasdaq: MMSI), a leading manufacturer and marketer of
proprietary disposable devices used primarily in cardiology and radiology
procedures, announced today that the Company will release its financial
results for the first quarter ended March 31, 2008, after the close of the
stock market on Thursday, April 24, 2008.

Merit will hold its investor conference call on the same day (Thursday,
April 24, 2008) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m.
Mountain, and 2:00 p.m. Pacific). The telephone numbers to call are
(domestic) 866-250-2351; and (international) 303-205-0044.

A live webcast will also be available for the conference call at
http://www.merit.com and http://www.fulldisclosure.com. To listen to the live broadcast,
please enter the site 10-15 minutes prior to the call in order to download
any necessary media players. Just click on the Investors tab on Merit's
home page. The webcast will be archived on both sites. There is no other
replay access to the call.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is engaged in the
development, manufacture and distribution of proprietary disposable medical
devices used in interventional and diagnostic procedures, particularly in
cardiology and radiology. Merit serves client hospitals worldwide with a
domestic and international sales force totaling approximately 90
individuals. Merit employs approximately 1,540 people worldwide, with
facilities in Salt Lake City and South Jordan, Utah; Angleton, Texas;
Richmond, Virginia; Maastricht and Venlo, The Netherlands; and Galway,
Ireland.

Statements contained in this release, which are not purely historical,
are forward-looking statements within the meaning of the Private Securities
Litigation Act of 1995 and are subject to risks and uncertainties such as
those described in Merit's Annual Report on Form 10-K for the year ended
December 31, 2007. Such risks and uncertainties include product recalls and
product liability claims; infringement of Merit's technology or the
assertion that Merit's technology infringes the rights of other parties;
termination of relationship with suppliers, or failure of suppliers to
perform; inability to successfully manage growth through acquisitions;
delays in obtaining regulatory approvals, or the failure to maintain such
approvals; concentration of Merit's revenues among a few products and
procedures; development of new products and technology that could render
Merit's products obsolete, market acceptance of new products, introduction
of products in a timely fashion, price and product competition,
availability of labor and materials, cost increases, and fluctuations in
and obsolescence of inventory; volatility of the market price of Merit's
common stock; foreign currency fluctuations; key personnel; work stoppage
or transportation risks; modification or limitation of governmental or
private insurance reimbursement, changes in health care markets related to
health care reform initiatives; and other factors referred to in Merit's
Annual Report on Form 10-K and other reports filed with the Securities and
Exchange Commission. All subsequent forward-looking statements attributable
to Merit or persons acting on its behalf are expressly qualified in their
entirety by these cautionary statements. Actual results may differ
materially from anticipated results. Financial estimates are subject to
change and are not intended to be relied upon as predictions of future
operating results, and Merit assumes no obligation to update or disclose
revisions to those estimates.

Contact: Anne-Marie Wright, Vice President of Corporate Communications

Phone: (801) 208-4167 e-mail: awright@merit.com





See Also

Via: Healthcare

Опубліковано prolink о 11:30 AM

0 коментарі:

Post a Comment

Subscribe to: Post Comments (Atom)